NCT07626086 Pilates Exercises on Balance, Fatigue and Quality of Life
| NCT ID | NCT07626086 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Cairo University |
| Condition | Renal Transplantation |
| Study Type | INTERVENTIONAL |
| Enrollment | 50 participants |
| Start Date | 2026-01-01 |
| Primary Completion | 2026-06-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 50 participants in total. It began in 2026-01-01 with a primary completion date of 2026-06-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Fifty patients of both genders with age 20- 50 year old suffering from physical and functional limitations after renal transplantation surgeries participated in this study. The participants were randomly distributed into two groups equal in number. Group (A): 25 patients who received Pilates exercises 3 times per week in addition to conventional physical therapy program with medical care for 12 weeks while control group (group B) (n =25) who received conventional physical therapy program with medical care for 12 weeks.
Eligibility Criteria
Inclusion Criteria: (1) Patients' age was ranged between 20-50 years old, (2) Both gender participated in this study, (3) All the patients were free from any neurological disorders, (4) All the patients were free from genitourinary infections, (5) All patients started the treatment program between 3 and 12 months following renal transplantation, (6) were not currently participating in any other regular physical exercise program, (7) Patients who were able to comprehend command and willing to participate in the study and (8) Informed consent was obtained from all patients enrolled in the trial. Exclusion Criteria: (1) Neuropathy issues, (2) Rheumatic diseases, (3) Orthopedic diseases, (4) Abdominal surgery of the upper or lower abdomen, (5) Patients who required acute respiratory intervention, (6) Patients who transferred to the intensive care unit, (7) Active smokers, (8) uncontrolled ABP, (9) Diabetics, (10) Chronic hepatitis, (11) Patients with pacemaker, (12) detection of reduced exercise tolerance, including tachycardia, shortness of breath, and feeling too tired or weak.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07626086 clinical trial?
This trial is open to participants of all sexes, aged 20 Years or older, up to 50 Years, studying Renal Transplantation. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07626086 currently recruiting?
Yes, NCT07626086 is actively recruiting participants. Contact the research team at eth.com@pt.cu.edu.eg for enrollment information.
Where is the NCT07626086 trial being conducted?
This trial is being conducted at Damanhur, Egypt, Giza, Egypt.
Who is sponsoring the NCT07626086 clinical trial?
NCT07626086 is sponsored by Cairo University. The trial plans to enroll 50 participants.